Reaction Details Report a problem with these data
Target
Serine protease HTRA1
Ligand
BDBM496998
Substrate
n/a
Meas. Tech.
Enzyme Inhibition Assay
IC50
0.889±n/a nM
Citation
 Hornsperger, B; Maerki, HP; Mohr, P; Reutlinger, M; Rudolph, M Difluoroketamide derivatives as HTRA1 inhibitors US Patent  US11001555 Publication Date 5/11/2021 
Target
Name:
Serine protease HTRA1
Synonyms:
HTRA | HTRA1 | HTRA1_HUMAN | PRSS11
Type:
Protein
Mol. Mass.:
51293.95
Organism:
Homo sapiens (Human)
Description:
Q92743
Residue:
480
Sequence:
MQIPRAALLPLLLLLLAAPASAQLSRAGRSAPLAAGCPDRCEPARCPPQPEHCEGGRARDACGCCEVCGAPEGAACGLQEGPCGEGLQCVVPFGVPASATVRRRAQAGLCVCASSEPVCGSDANTYANLCQLRAASRRSERLHRPPVIVLQRGACGQGQEDPNSLRHKYNFIADVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQGKLPVLLLGRSSELRPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNSGGPLVNLDGEVIGINTLKVTAGISFAIPSDKIKKFLTESHDRQAKGKAITKKKYIGIRMMSLTSSKAKELKDRHRDFPDVISGAYIIEVIPDTPAEAGGLKENDVIISINGQSVVSANDVSDVIKRESTLNMVVRRGNEDIMITVIPEEIDP
  
Inhibitor
Name:
BDBM496998
Synonyms:
N-[(2S)-3-(3-chlorophenyl)-1-[(2S,4R)-2-[[(3S)-5,5-difluoro-2-methyl-4,6-dioxo-6-(2,2,2-trifluoroethylamino)hexan-3-yl]carbamoyl]-4-[(4-methoxyphenyl)methoxy]pyrrolidin-1-yl]-1-oxopropan-2-yl]pyridine-2-carboxamide | US11001555, Example 22
Type:
Small organic molecule
Emp. Form.:
C37H39ClF5N5O7
Mol. Mass.:
796.18
SMILES:
COc1ccc(CO[C@@H]2C[C@H](N(C2)C(=O)[C@H](Cc2cccc(Cl)c2)NC(=O)c2ccccn2)C(=O)N[C@@H](C(C)C)C(=O)C(F)(F)C(=O)NCC(F)(F)F)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: